Arthritis & Rheumatism · 1996 · 70 citations · 21 references
MedicineCell BiologyImmunologyAutoimmunityInflammationRheumatologyAutoimmune Rheumatic DiseasesJoint DiseaseJoint PathologyOsteoarthritisRheumatoid ArthritisSynovial InflammationFlow Cytometry ImmunophenotypingImmune Cell ActivationImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingSynovial BiomarkersSynovial Fluid Cell Analysis
Abstract Objective . To investigate the expressions of costimulatory molecules CD86 (B7‐2, B70) and CD28 by cells obtained from the synovial tissues (ST) and synovial fluids (SF) of patients with rheumatoid arthritis (RA). Methods . Monoclonal antibodies (MAb) against CD86 and CD28 were used for immunochemical study of synovia from 18 RA patients, 4 osteoarthritis (OA) patients, and 4 normal subjects. These MAb were also used for flow cytometry of isolated ST cells from 8 RA and 5 OA patients and of SF mononuclear cells from 5 RA and 5 OA patients. Results . Immunohistochemical examination revealed that CD86+ cells occurred in 11 of the 18 RA synovia, but in none of the 4 OA or 4 normal synovia. Most of the positive cells had macrophage‐like morphology, and surrounded lymphoid aggregates. Most cells within lymphoid aggregates were stained positively for CD28. Flow cytometry showed that CD86+ cells comprised 2.9–33.4% (average 14.3%) of the total ST cells and 2.1–14.9% (average 6.1%) of the total SF mononuclear cells from RA patients. Approximately 40% of the CD86+ cells expressed CD14. A majority (mean 72%, range 57–89%) of the T cells in ST and SF expressed CD28. RA synovia expressed more CD86 molecules than did OA synovia (mean frequency of positive cells 14.3% versus 2.8%; mean fluorescence intensity 104.6 versus 40.9). Conclusion . This study has shown that the expression of the CD86 molecule was up‐regulated in RA synovia. The CD86+ cells appeared macrophage‐like and surrounded CD28+ cells in lymphoid aggregates. The simultaneous presence and close localization of CD86+ and CD28+ cells in the RA synovial compartment suggests that their interaction potentially contributes to the sustained immune activation of RA.
21
CTLA-4 is a second receptor for the B cell activation antigen B7.
Peter S. Linsley, William Brady, M Urnes et al. · The Journal of Experimental Medicine · 1991 · 1.7K citations · Full text
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
Deborah J. Lenschow, Yijun Zeng, J. Richard Thistlethwaite et al. · Science · 1992 · 1.1K citations
B70 antigen is a second ligand for CTLA-4 and CD28
Miyuki Azuma, Daisuke Ito, Hideo Yagita∥ et al. · Nature · 1993 · 915 citations